Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lloyd George W.
EVP, Investments & CLO at Royalty Pharma. Filing since 18 Jun 2020.
CIK 0001814899
Company
Date
Role
Action
Shares
Amount
Of holding
RPRX
Royalty Pharma plc
18 Dec 2025
EVP, Investments & CLO
Sold on a plan
30,654
$1.18M
100%
RPRX
Royalty Pharma plc
17 Dec 2025
EVP, Investments & CLO
Sold on a plan
79,346
$3.06M
72.1%
RPRX
Royalty Pharma plc
3 Dec 2025
EVP, Investments & CLO
Sold on a plan
110,000
$4.38M
50.0%
RPRX
Royalty Pharma plc
19 Nov 2025
EVP, Investments & CLO
Sold on a plan
132,426
$5.08M
100%
RPRX
Royalty Pharma plc
19 Nov 2025
EVP, Investments & CLO
Sold on a plan
3,000
$115.03K
100%
RPRX
Royalty Pharma plc
6 Jun 2023
EVP, Investments & CLO
Sold at will
79,099
$2.67M
72.5%
RPRX
Royalty Pharma plc
5 Jun 2023
EVP, Investments & CLO
Sold at will
19,215
$644.45K
15.0%
RPRX
Royalty Pharma plc
2 Jun 2023
EVP, Investments & CLO
Sold at will
93,907
$3.16M
43.9%
RPRX
Royalty Pharma plc
29 Mar 2023
EVP, Investments & CLO
Sold at will
12,779
$473.17K
5.7%
RPRX
Royalty Pharma plc
28 Mar 2023
EVP, Investments & CLO
Sold at will
100,000
$3.71M
30.8%
RPRX
Royalty Pharma plc
23 Feb 2023
EVP, Investments & CLO
Sold, plan not stated
25,000
$931.66K
7.1%
RPRX
Royalty Pharma plc
22 Nov 2022
EVP, Investments & CLO
Sold, plan not stated
16,369
$706.85K
11.2%
RPRX
Royalty Pharma plc
21 Nov 2022
EVP, Investments & CLO
Sold, plan not stated
23,631
$1.02M
14.1%
RPRX
Royalty Pharma plc
10 Nov 2022
EVP, Investments & CLO
Sold, plan not stated
50,000
$2.19M
23.3%
RPRX
Royalty Pharma plc
10 Aug 2022
EVP, Investments & GC
Sold, plan not stated
8,995
$395.11K
4.3%
RPRX
Royalty Pharma plc
9 Aug 2022
EVP, Investments & GC
Sold, plan not stated
11,859
$520.80K
5.3%
RPRX
Royalty Pharma plc
28 Jul 2022
EVP, Investments & GC
Sold, plan not stated
4,046
$177.89K
1.8%
RPRX
Royalty Pharma plc
27 Jul 2022
EVP, Investments & GC
Sold, plan not stated
25,100
$1.10M
10.0%
RPRX
Royalty Pharma plc
26 Jul 2022
EVP, Investments & GC
Sold, plan not stated
19,329
$833.05K
7.9%
RPRX
Royalty Pharma plc
25 Jul 2022
EVP, Investments & GC
Sold, plan not stated
30,671
$1.32M
11.8%
RPRX
Royalty Pharma plc
27 May 2022
EVP, Investments & GC
Sold, plan not stated
13,974
$569.75K
3.1%
RPRX
Royalty Pharma plc
26 May 2022
EVP, Investments & GC
Sold, plan not stated
86,026
$3.46M
16.2%
RPRX
Royalty Pharma plc
23 May 2022
EVP, Investments & GC
Sold, plan not stated
100,000
$4.03M
15.9%
RPRX
Royalty Pharma plc
17 Nov 2021
EVP, Investments & GC
Sold, plan not stated
84,148
$3.57M
11.8%
RPRX
Royalty Pharma plc
16 Nov 2021
EVP, Investments & GC
Sold, plan not stated
165,852
$7.03M
25.1%
RPRX
Royalty Pharma plc
26 Jul 2021
EVP, Investments & GC
Sold, plan not stated
13,362
$531.53K
2.2%
RPRX
Royalty Pharma plc
13 Jul 2021
EVP, Investments & GC
Sold, plan not stated
23,049
$968.25K
3.7%
RPRX
Royalty Pharma plc
12 Jul 2021
EVP, Investments & GC
Sold, plan not stated
100
$4.20K
0.0%
RPRX
Royalty Pharma plc
8 Jul 2021
EVP, Investments & GC
Sold, plan not stated
49,059
$2.06M
7.5%
RPRX
Royalty Pharma plc
7 Jul 2021
EVP, Investments & GC
Sold, plan not stated
2,900
$121.83K
0.5%
RPRX
Royalty Pharma plc
6 Jul 2021
EVP, Investments & GC
Sold, plan not stated
36,530
$1.55M
5.6%
RPRX
Royalty Pharma plc
10 Jun 2021
EVP, Investments & GC
Sold, plan not stated
70,000
$3.25M
22.6%
RPRX
Royalty Pharma plc
8 Jun 2021
EVP, Investments & GC
Sold, plan not stated
70,000
$3.25M
21.9%
RPRX
Royalty Pharma plc
7 Jun 2021
EVP, Investments & GC
Sold, plan not stated
122,500
$5.68M
32.0%
RPRX
Royalty Pharma plc
4 Jun 2021
EVP, Investments & GC
Sold, plan not stated
60,000
$2.69M
17.6%
RPRX
Royalty Pharma plc
2 Jun 2021
EVP, Investments & GC
Sold, plan not stated
62,500
$2.63M
8.1%
RPRX
Royalty Pharma plc
14 Apr 2021
EVP, Investments & GC
Sold, plan not stated
69,822
$2.94M
58.3%
RPRX
Royalty Pharma plc
12 Apr 2021
EVP, Investments & GC
Sold, plan not stated
449
$19.00K
0.7%
RPRX
Royalty Pharma plc
22 Mar 2021
EVP, Investments & GC
Sold, plan not stated
54,729
$2.54M
46.1%
RPRX
Royalty Pharma plc
2 Mar 2021
EVP, Investments & GC
Sold, plan not stated
125,000
$5.87M
62.5%
RPRX
Royalty Pharma plc
18 Jun 2020
EVP, Investments & GC
Bought
11,200
$313.60K
opened
RPRX
Royalty Pharma plc
18 Jun 2020
EVP, Investments & GC
Bought
3,000
$84.00K
opened
42 decisions on file.
